Oxyle, a Zurich, Switzerland-based developer of wastewater therapy know-how, raised CHF2.8M in Pre-Seed funding.
The spherical was led by Wingman Ventures with participation from SOSV, Better Ventures, and one other.vc. Including this spherical, with pre-seed non-dilutive funds and grants raised final yr, Oxyle has raised over CHF 7 million in complete.
The firm intends to make use of the funds to strengthen the workforce with upscaling capacities, increase its buyer portfolio into market segments, construct partnerships to enter new places, and to deliver its first product to market subsequent yr.
Led by CEO Dr. Fajer Mushtaq and CTO Dr. Silvan Staufert, Oxyle offers a complicated wastewater therapy and monitoring answer that eliminates persistent and poisonous micropollutants from water in a sustainable method. The know-how destroys a variety of micropollutants together with the ceaselessly chemical substances reminiscent of PFAS, prescribed drugs, hormones, pesticides and so forth. from contaminated wastewater.